This investigation encompassed a comprehensive analysis of FXR1 across a spectrum of cancer subtypes, uncovering significant correlations between FXR1 expression and clinical prognostic outcomes, mutational profiles, and the presence of immune cell infiltrations. The gene discussed is FXR1; the disease is cancer.